Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: sophiegirl, some more reading for you...

sophiegirl, some more reading for you...

posted on Dec 10, 2007 02:41PM

http://www.uspto.gov/web/offices/pac/mpep/documents/2200.htm

 

Please let me know if there is anything that you are unsure about, for example,

2269 Reconsideration

In order to be entitled to reconsideration, the patent owner must respond to the Office action. 37 CFR 1.111(b). The patent owner may respond to such Office action with or without amendment and the patent under reexamination will be reconsidered, and so on repeatedly unless the examiner has indicated that the action is final. See 37 CFR 1.112. Any amendment after the second Office action, which will normally be final as provided for in MPEP § 2271, must ordinarily be restricted to the rejection or to the objection or requirement made.

 

 

 

Be well

7
Dec 10, 2007 03:19PM
1
Dec 10, 2007 03:33PM

Dec 10, 2007 03:39PM
Share
New Message
Please login to post a reply